Exploring the Professional Issue of Group B Streptococcus Screening in Pregnancy

What is it about?

Throughout pregnancy women are offered a variety of screenings and diagnostic procedures. Group B Streptococcus (GBS) screening is currently a routine screening process in Australia, but not in the United Kingdom (UK), and which is offered to women at 35-37 weeks gestation. The results of GBS screening alter a woman’s course of care for labour and the postnatal period. This paper is a review of evidence, policy and clinical practice, and aims to determine whether GBS screening is necessary and whether the screening has a positive or negative impact upon women and their babies.

Featured Image